Biotinylated liposomes as potential carriers for the oral delivery of insulin

Carino, 1999, Oral insulin delivery, Adv Drug Deliv Rev, 35, 249, 10.1016/S0169-409X(98)00075-1

Wang, 2012, pH-sensitive polymeric nanoparticles to improve oral bioavailability of peptide/protein drugs and poorly water-soluble drugs, Eur J Pharm Biopharm, 82, 219, 10.1016/j.ejpb.2012.07.014

Nakamura, 2004, Oral insulin delivery using P(MAA-g-EG) hydrogels: effects of network morphology on insulin delivery characteristics, J Control Release, 95, 589, 10.1016/j.jconrel.2003.12.022

Sharma, 2010, Microemulsions for oral delivery of insulin: design, development and evaluation in streptozotocin induced diabetic rats, Eur J Pharm Biopharm, 76, 159, 10.1016/j.ejpb.2010.07.002

Zhang, 2011, Preparation and evaluation of alginate-chitosan microspheres for oral delivery of insulin, Eur J Pharm Biopharm, 77, 11, 10.1016/j.ejpb.2010.09.016

Chung, 2002, Self-assembled “nanocubicle" as a carrier for peroral insulin delivery, Diabetologia, 45, 448, 10.1007/s00125-001-0751-z

Lee, 2010, A novel approach to oral delivery of insulin by conjugating with low molecular weight chitosan, Bioconjug Chem, 21, 1720, 10.1021/bc100093v

Chen, 2011, A review of the prospects for polymeric nanoparticle platforms in oral insulin delivery, Biomaterials, 32, 9826, 10.1016/j.biomaterials.2011.08.087

Kisel, 2001, Liposomes with phosphatidylethanol as a carrier for oral delivery of insulin: studies in the rat, Int J Pharm, 216, 105, 10.1016/S0378-5173(01)00579-8

Zhang, 2005, Investigation of lectin-modified insulin liposomes as carriers for oral administration, Int J Pharm, 294, 247, 10.1016/j.ijpharm.2005.01.018

Makhlof, 2011, In vitro and in vivo evaluation of WGA-carbopol modified liposomes as carriers for oral peptide delivery, Eur J Pharm Biopharm, 77, 216, 10.1016/j.ejpb.2010.12.008

Niu, 2011, Liposomes containing glycocholate as potential oral insulin delivery systems: preparation, in vitro characterization, and improved protection against enzymatic degradation, Int J Nanomedicine, 6, 1155

Wu, 2004, Hypoglycemic efficacy of chitosan-coated insulin liposomes after oral administration in mice, Acta Pharmacol Sin, 25, 966

Takeuchi, 2009, Chitosan-aprotinin coated liposomes for oral peptide delivery: development, characterisation and in vivo evaluation, Int J Pharm, 370, 26, 10.1016/j.ijpharm.2008.11.013

Katayama, 2003, Double liposomes: hypoglycemic effects of liposomal insulin on normal rats, Drug Dev Ind Pharm, 29, 725, 10.1081/DDC-120021771

Ye, 2000, DepoFoam (TM) technology: a vehicle for controlled delivery of protein and peptide drugs, J Control Release, 64, 155, 10.1016/S0168-3659(99)00146-7

Hamman, 2007, Targeting receptors, transporters and site of absorption to improve oral drug delivery, Drug Target Insights., 2, 71, 10.1177/117739280700200003

Swaan, 1998, Recent advances in intestinal macromolecular drug delivery via receptor-mediated transport pathways, Pharm Res, 15, 826, 10.1023/A:1011908128045

Russell-Jones, 2004, Use of targeting agents to increase uptake and localization of drugs to the intestinal epithelium, J Drug Target, 12, 113, 10.1080/10611860410001693760

Ling, 2009, Oral bioavailability enhancement of a hydrophilic drug delivered via folic acid-coupled liposomes in rats, J Pharm Pharmacol, 61, 445, 10.1211/jpp.61.04.0005

Chalasani, 2007, Effective oral delivery of insulin in animal models using vitamin B12-coated dextran nanoparticles, J Control Release, 122, 141, 10.1016/j.jconrel.2007.05.019

Chalasani, 2007, A novel vitamin B12-nanosphere conjugate carrier system for peroral delivery of insulin, J Control Release, 117, 421, 10.1016/j.jconrel.2006.12.003

Chae, 2008, Preparation, characterization, and application of biotinylated and biotin-PEGylated glucagon-like peptide-1 analogues for enhanced oral delivery, Bioconjug Chem, 19, 334, 10.1021/bc700292v

Petrus, 2009, Traveling the vitamin B12 pathway: oral delivery of protein and peptide drugs, Angew Chem Int Ed, 48, 1022, 10.1002/anie.200800865

Chatterjee, 1999, Molecular mechanism of the intestinal biotin transport process, Am J Physiol-Cell Ph., 277, C605, 10.1152/ajpcell.1999.277.4.C605

Youn, 2008, Improved peroral delivery of glucagon-like peptide-1 by site-specific biotin modification: design, preparation, and biological evaluation, Eur J Pharm Biopharm, 68, 667, 10.1016/j.ejpb.2007.07.009

Mirochnik, 2007, Targeting of biotinylated oligonucleotides to prostate tumors with antibody-based delivery vehicles, J Drug Target, 15, 342, 10.1080/10611860701350099

Sigot, 2010, Targeted cellular delivery of quantum dots loaded on and in biotinylated liposomes, Bioconjug Chem, 21, 1465, 10.1021/bc100054c

Kim, 2012, Synthesis and evaluation of biotin-conjugated pH-responsive polymeric micelles as drug carriers, Int J Pharm, 427, 435, 10.1016/j.ijpharm.2012.01.034

Yellepeddi, 2011, Biotinylated PAMAM dendrimers for intracellular delivery of cisplatin to ovarian cancer: role of SMVT, Anticancer Res, 31, 897

Chen, 2013, Influence of lipid composition on the phase transition temperature of liposomes composed of both DPPC and HSPC, Drug Dev Ind Pharm, 39, 197, 10.3109/03639045.2012.668912

Li, 2013, Nanoemulsions coated with alginate/chitosan as oral insulin delivery systems: preparation, characterization, and hypoglycemic effect in rats, Int J Nanomedicine, 8, 23

Niu, 2012, Hypoglycemic activity and oral bioavailability of insulin-loaded liposomes containing bile salts in rats: the effect of cholate type, particle size and administered dose, Eur J Pharm Biopharm, 81, 265, 10.1016/j.ejpb.2012.02.009

Jain, 2012, Folate-decorated PLGA nanoparticles as a rationally designed vehicle for the oral delivery of insulin, Nanomedicine, 7, 1311, 10.2217/nnm.12.31

Kuolee, 2008, M cell-targeted delivery of vaccines and therapeutics, Expert Opin Drug Deliv, 5, 693, 10.1517/17425247.5.6.693

Al-Hajaj, 2011, Short ligands affect modes of QD uptake and elimination in human cells, ACS Nano, 5, 4909, 10.1021/nn201009w

Du, 2013, Transferrin receptor specific nanocarriers conjugated with functional 7peptide for oral drug delivery, Biomaterials, 34, 794, 10.1016/j.biomaterials.2012.10.003

Ivanov, 2008, Pharmacological inhibition of endocytic pathways: is it specific enough to be useful?, Vol 440, 15